Literature DB >> 3899661

Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors.

W Friedrich, S F Goldmann, W Ebell, R Blütters-Sawatzki, G Gaedicke, A Raghavachar, H H Peter, B Belohradsky, W Kreth, B Kubanek.   

Abstract

In 15 infants with severe combined immunodeficiency (SCID), immunological reconstitution was attempted by bone marrow transplantation (BMT) from HLA-haplo-identical parents. To prevent graft versus host disease (GvHD), marrow grafts were depleted of contaminating T-lymphocytes using lectin agglutination and rosette formation with sheep red blood cells. Thirteen patients received transplants without undergoing prior cytoreductive conditioning. Eleven of these developed donor-dependent T-cell functions, two failed to do this. One of these two as well as two further patients received cytoreductive treatment prior to repeat and to first transplants and in two, complete lymphohemopoietic reconstitution was observed. Of the 15 patients who received transplants, 11 are currently alive. Two recently treated patients remain in the hospital, nine are at home with stable T-cell functions. Normal humoral immune functions have developed upto now in three patients. In the others, gamma globulins are regularly substituted. Complications of acute or chronic GvHD were not observed with the exception of one case who developed transient GvHD of the skin. These results suggest that in a majority of patients with SCID, T-cell functions can develop without GvHD following haploidentical, T-cell-depleted BMT. Exceptional patients require preconditioning to allow donor cell engraftment, an approach that also appears to facilitate reconstitution of humoral immune functions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899661     DOI: 10.1007/bf00451897

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  Is the B-cell abnormality secondary to T-cell abnormality in severe combined immunodeficiency?1.

Authors:  R S Geha
Journal:  Clin Immunol Immunopathol       Date:  1976-07

Review 2.  The biochemical basis of immunodeficiency disease.

Authors:  K O Raivio
Journal:  Eur J Pediatr       Date:  1980-10       Impact factor: 3.183

Review 3.  Marrow transplantation for congenital disorders.

Authors:  R J O'Reilly; J Brochstein; R Dinsmore; D Kirkpatrick
Journal:  Semin Hematol       Date:  1984-07       Impact factor: 3.851

4.  Failure of a pan-reactive anti-T cell antibody, OKT 3, to prevent graft versus host disease in severe combined immunodeficiency.

Authors:  A R Hayward; S Murphy; J Githens; G Troup; D Ambruso
Journal:  J Pediatr       Date:  1982-04       Impact factor: 4.406

5.  Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.

Authors:  H Glucksberg; R Storb; A Fefer; C D Buckner; P E Neiman; R A Clift; K G Lerner; E D Thomas
Journal:  Transplantation       Date:  1974-10       Impact factor: 4.939

6.  Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells.

Authors:  Y Reisner; N Kapoor; D Kirkpatrick; M S Pollack; B Dupont; R A Good; R J O'Reilly
Journal:  Lancet       Date:  1981-08-15       Impact factor: 79.321

7.  Absence of lymphocyte ecto-5'-nucleotidase in infants with reticuloendotheliosis and eosinophilia (Omenn's syndrome).

Authors:  E W Gelfand; D McCurdy; C P Rao; A Cohen
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

8.  Combined immunodeficiency and reticuloendotheliosis with eosinophilia.

Authors:  H D Ochs; S D Davis; E Mickelson; K G Lerner; R J Wedgwood
Journal:  J Pediatr       Date:  1974-10       Impact factor: 4.406

9.  Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow.

Authors:  W Friedrich; S F Goldmann; U Vetter; T M Fliedner; B Heymer; H H Peter; Y Reisner; E Kleihauer
Journal:  Lancet       Date:  1984-04-07       Impact factor: 79.321

10.  Heterogeneity of b lymphocyte differentiation in severe combined immunodeficiency disease.

Authors:  S G Pahwa; R N Pahwa; R A Good
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

View more
  16 in total

Review 1.  Severe combined immunodeficiencies (SCID).

Authors:  A Fischer
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Oligoclonal expansion of CD45RO+ T lymphocytes in Omenn syndrome.

Authors:  T O Harville; D M Adams; T A Howard; R E Ware
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

3.  Accelerated development of immunity following transplantation of maternal marrow stem cells into infants with severe combined immunodeficiency and transplacentally acquired lymphoid chimerism.

Authors:  M J Barrett; R H Buckley; S E Schiff; P C Kidd; F E Ward
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

Review 4.  Novel strategies for adoptive therapy following HLA disparate transplants.

Authors:  Richard J O'Reilly; Aisha Hasan; Ekaterina Doubrovina; Guenther Koehne; Susan Prockop
Journal:  Best Pract Res Clin Haematol       Date:  2011-09       Impact factor: 3.020

5.  Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome.

Authors:  Manfred Hoenig; Chantal Lagresle-Peyrou; Ulrich Pannicke; Luigi D Notarangelo; Fulvio Porta; Andrew R Gennery; Mary Slatter; Morton J Cowan; Polina Stepensky; Hamoud Al-Mousa; Daifulah Al-Zahrani; Sung-Yun Pai; Waleed Al Herz; Hubert B Gaspar; Paul Veys; Koichi Oshima; Kohsuke Imai; Hiromasa Yabe; Lenora M Noroski; Nico M Wulffraat; Karl-Walter Sykora; Pere Soler-Palacin; Hideki Muramatsu; Mariam Al Hilali; Despina Moshous; Klaus-Michael Debatin; Catharina Schuetz; Eva-Maria Jacobsen; Ansgar S Schulz; Klaus Schwarz; Alain Fischer; Wilhelm Friedrich; Marina Cavazzana
Journal:  Blood       Date:  2017-03-22       Impact factor: 22.113

Review 6.  Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review.

Authors:  M Teresa de la Morena; Robert P Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

Review 7.  Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.

Authors:  Rebecca H Buckley
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

8.  Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs.

Authors:  Linda M Griffith; Morton J Cowan; Donald B Kohn; Luigi D Notarangelo; Jennifer M Puck; Kirk R Schultz; Rebecca H Buckley; Mary Eapen; Naynesh R Kamani; Richard J O'Reilly; Robertson Parkman; Chaim M Roifman; Kathleen E Sullivan; Alexandra H Filipovich; Thomas A Fleisher; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2008-11-06       Impact factor: 10.793

9.  Expansion of CD3+CD4-CD8- T cell population expressing high levels of IL-5 in Omenn's syndrome.

Authors:  I Melamed; A Cohen; C M Roifman
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

Review 10.  Allogeneic stem cell transplantation for treatment of immunodeficiency.

Authors:  Wilhelm Friedrich; Susanna M Müller
Journal:  Springer Semin Immunopathol       Date:  2004-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.